4//SEC Filing
Sidhu Roger 4
Accession 0001140361-21-032105
CIK 0000748592other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:57 PM ET
Size
8.1 KB
Accession
0001140361-21-032105
Insider Transaction Report
Form 4
Sidhu Roger
See Remarks
Transactions
- Award
Stock Option
2021-09-20+161,300→ 161,300 totalExercise: $9.96Exp: 2031-09-20→ Common Stock (161,300 underlying) - Award
Restricted Stock Unit
2021-09-20+80,650→ 80,650 totalExp: 2031-09-20→ Common Stock (80,650 underlying)
Footnotes (3)
- [F1]The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on September 20, 2022, and 1/36 of the remaining shares covered thereby vesting on the twentieth day of each calendar month from October 2022 through September 20, 2025, subject to continued service through each vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]The RSU Grant vests and becomes exercisable in four equal installments on September 20 of each of 2022, 2023, 2024 and 2025, provided that it shall vest in full immediately prior to a change in control (as defined in Dr. Sidhu's Executive Employment Agreement, effective September 20, 2021), subject to continued service through each vesting date.
Documents
Issuer
Brooklyn ImmunoTherapeutics, Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001884115
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:57 PM ET
- Size
- 8.1 KB